A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...

Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to ...

A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...

Virtual specialty care platform AmplifyMD, which aims to help hospitals do more with fewer doctors, scored $20 million dollars this Wednesday in a Series B financing round led by Forerunner Ventures.

During the MedCity INVEST Digital Health conference in Dallas, three executives shared what’s top of mind as they deploy AI in the healthcare workforce, including the need to build trust and improve ...

During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.

From left to right: Soumi Saha, senior vice president of government affairs at Premier Inc.; Jennifer Goldsack, founder and CEO of the Digital Medicine Society Hallucinations are a frequent point of ...

The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...

Coronary disease is one of the most significant causes of death among women in the United States; it is responsible for one in every three deaths. Advancing age, along with other contributing factors, ...

AI agents — autonomous, task-specific systems designed to perform functions with little or no human intervention — are gaining traction in the healthcare world. The industry is under massive pressure ...

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...